Search Result

• All
• Related Products
• Other Content

• Capricor Reports Positive Phase 3 HOPE-3 Results: Deramiocel Demonstrates Skeletal and Cardiac Benefits in Duchenne Muscular Dystrophy December 3, 2025 — Capricor Therapeutics announced that its investigational cell therapy Deramiocel achieved both primary and key secondary endpoints in the pivotal Phase 3 HOPE-3 trial for Duchenne ... More+
• Instructions for Use of Lentivirus Titer p24 ELISA Detection Kit
• Vertex’s Gene Therapy Casgevy Shows Strong Efficacy in Younger Children with Blood Disorders Boston, December 6, 2025Vertex Pharmaceuticals announced new clinical data demonstrating that its gene-editing therapy Casgevy (exagamglogene autotemcel, exa-cel) produced robust therapeutic benefits ... More+
• Instructions for Use of Mycoplasma DNA Detection Kit (qPCR)-ZY001
• Instructions for Use of Mycoplasma DNA Detection Kit (qPCR)-ZY002
• FDA Approves First Gene Therapy for Rare Immune Disorder Wiskott-Aldrich Syndrome, Expanding Treatment to Patients Aged 6 Months and Older Washington, Dec. 9, 2025 — The U.S. Food and Drug Administration (FDA) has approved Waskyra (etuvetidigene autotemcel), a gene therapy developed by nonprofit organization Fondazione Telethon ETS, for... More+
• Instructions for Use of Mycoplasma Residual DNA Sample Pretreatment Kit (Magnetic Bead Method)-CL200
• FDA Approves BioCryst’s Oral Pellet Form of Orladeyo, First Oral Prophylactic Therapy for Children Aged 2–11 with HAE Durham, NC — Dec. 12, 2025 — The U.S. Food and Drug Administration (FDA) has approved an oral pellet formulation of Orladeyo (berotralstat) from BioCryst Pharmaceuticals for prophylactic use in chil... More+
• Instructions for Use of NK and TIL Cell Expansion Reagents (K562 Feeder Cell)
• Sanofi Signs Up to $1.04 Billion Alzheimer’s Drug Development Deal with South Korea’s ADEL Paris / Seoul — Dec. 15, 2025 — French pharmaceutical company Sanofi has entered into a strategic collaboration with South Korean biotech firm ADEL worth up to USD 1.04 billion to jointly develop an... More+
• Instructions for Use of NK Cll Expansion Kit
• UAE Becomes Second Country to Approve Gene Therapy Itvisma for Spinal Muscular Atrophy The United Arab Emirates has become the second country in the world to approve the gene therapy Itvisma for the treatment of spinal muscular atrophy (SMA), marking another milestone in the global adop... More+
• Instructions for Use of PG13 Residual DNA Detection Kit (qPCR)
• FDA Approves Omeros’ Yartemlea as First Treatment for Transplant-Associated Thrombotic Microangiopathy Washington, Dec. 24, 2025 — The U.S. Food and Drug Administration has approved Yartemlea, a monoclonal antibody developed by Omeros Corporation, as the first treatment for transplant-associated throm... More+
• Instructions for Use of Plasmid Residual DNA (Kanamycin Resistance Gene) Detection Kit (qPCR)